Management of Metastatic Mucinous Adenocarcinoma

Critical Initial Diagnostic Step: Establish Primary Site

• The American College of Physicians recommends measuring CA-125/CEA ratio to differentiate between gastrointestinal and ovarian primary sites, with a ratio ≤25:1 suggesting gastrointestinal primary 2
• The National Comprehensive Cancer Network suggests performing upper and lower endoscopy if CEA or CA 19-9 are elevated to evaluate for gastrointestinal primary 2
• The College of American Pathologists recommends using PAX8 immunostaining to differentiate primary from metastatic disease 1
• The Society of Gynecologic Oncology advises mandatory appendectomy at primary surgery for all suspected or confirmed mucinous ovarian tumors to exclude appendiceal primary 1, 2

Site-Specific Treatment Algorithms

Metastatic Ovarian Mucinous Adenocarcinoma

• The American College of Obstetricians and Gynecologists recommends postoperative options including observation, intravenous carboplatin with paclitaxel or docetaxel, 5-FU/leucovorin/oxaliplatin, or capecitabine/oxaliplatin for Stage IC disease 1
• The National Cancer Institute suggests using standard epithelial ovarian cancer chemotherapy regimens, such as carboplatin/paclitaxel, for Stages II-IV disease 1

Metastatic Esophageal/GEJ Mucinous Adenocarcinoma

• The European Society for Medical Oncology recommends treating according to standard metastatic gastric cancer protocols, with first-line doublet platinum-fluoropyrimidine chemotherapy for good performance status 3, 5
• The American Society of Clinical Oncology suggests considering triplet platinum-fluoropyrimidine-taxane regimen for very fit patients with bulky/symptomatic disease, though no overall survival benefit over doublet therapy 3, 5
• The National Comprehensive Cancer Network advises adding trastuzumab to chemotherapy backbone for HER2-positive disease 3, 4, 5

Common Pitfalls to Avoid

• The American College of Physicians warns against failure to exclude metastatic disease, emphasizing the importance of comprehensive gastrointestinal evaluation and CEA measurement before assuming ovarian primary 1, 2
• The Society of Gynecologic Oncology cautions against omitting appendectomy during primary surgery for suspected mucinous ovarian tumors, which risks missing appendiceal primary 1, 2